- Works count
- 578
- Citation count
- 45,594
- H-index
- 69
- i10-index
- 214
Research interests
Publications
Myocardial ischemia-reperfusion injury and the influence of inflammation
Trends in Cardiovascular Medicine · 2022 · https://doi.org/10.1016/j.tcm.2022.02.005
The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: a multinational randomized trial
Nature Medicine · 2022 · https://doi.org/10.1038/s41591-021-01659-1
Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction
New England Journal of Medicine · 2022 · https://doi.org/10.1056/nejmoa2206286
Baseline Characteristics of Patients With HF With Mildly Reduced and Preserved Ejection Fraction
JACC Heart Failure · 2022 · https://doi.org/10.1016/j.jchf.2021.11.006
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
European Heart Journal · 2021 · https://doi.org/10.1093/eurheartj/ehab368
Empagliflozin in Heart Failure with a Preserved Ejection Fraction
New England Journal of Medicine · 2021 · https://doi.org/10.1056/nejmoa2107038
Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure
New England Journal of Medicine · 2020 · https://doi.org/10.1056/nejmoa2022190
Single-Cell RNA Sequencing Analysis Reveals a Crucial Role for CTHRC1 (Collagen Triple Helix Repeat Containing 1) Cardiac Fibroblasts After Myocardial Infarction
Circulation · 2020 · https://doi.org/10.1161/circulationaha.119.044557
Early goal-directed haemodynamic optimization of cerebral oxygenation in comatose survivors after cardiac arrest: the Neuroprotect post-cardiac arrest trial
European Heart Journal · 2019 · https://doi.org/10.1093/eurheartj/ehz120
Position Paper of the European Society of Cardiology Working Group Cellular Biology of the Heart: cell-based therapies for myocardial repair and regeneration in ischemic heart disease and heart failure
European Heart Journal · 2016 · https://doi.org/10.1093/eurheartj/ehw113
Doxorubicin-induced cardiomyopathy: From molecular mechanisms to therapeutic strategies
Journal of Molecular and Cellular Cardiology · 2012 · https://doi.org/10.1016/j.yjmcc.2012.03.006
Cardiovascular Side Effects of Cancer Therapies: A Position Statement from the Heart Failure Association of the European Society of Cardiology
European Journal of Heart Failure · 2010 · https://doi.org/10.1093/eurjhf/hfq213
Inflammation as a Therapeutic Target in Heart Failure? A Scientific Statement from the Translational Research Committee of the Heart Failure Association of the European Society of Cardiology
European Journal of Heart Failure · 2009 · https://doi.org/10.1093/eurjhf/hfn043
The Myoblast Autologous Grafting in Ischemic Cardiomyopathy (MAGIC) Trial
Circulation · 2008 · https://doi.org/10.1161/circulationaha.107.734103
Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trial
The Lancet · 2006 · https://doi.org/10.1016/s0140-6736(05)67861-0
Increased Cardiac Expression of Tissue Inhibitor of Metalloproteinase-1 and Tissue Inhibitor of Metalloproteinase-2 Is Related to Cardiac Fibrosis and Dysfunction in the Chronic Pressure-Overloaded Human Heart
Circulation · 2005 · https://doi.org/10.1161/circulationaha.104.516963
Cardiomyocyte-Specific Overexpression of Nitric Oxide Synthase 3 Improves Left Ventricular Performance and Reduces Compensatory Hypertrophy After Myocardial Infarction
Circulation Research · 2004 · https://doi.org/10.1161/01.res.0000126497.38281.23
Human Endothelial Nitric Oxide Synthase Gene Transfer Inhibits Vascular Smooth Muscle Cell Proliferation and Neointima Formation After Balloon Injury in Rats
Circulation · 1998 · https://doi.org/10.1161/01.cir.97.13.1274
Cloning and expression of a cDNA encoding human endothelium-derived relaxing factor/nitric oxide synthase.
Journal of Biological Chemistry · 1992 · https://doi.org/10.1016/s0021-9258(18)42066-2
Current projects
No projects listed.